Pfizer said it would sell its patented medicines and vaccines—including for Covid-19, breast cancer and pneumonia—to low-income countries on a not-for-profit basis.
The U.S. Strategic National Reserve includes 1.7 million doses of tecovirimat—a smallpox treatment that might also be effective against monkeypox, a rare disease that has been diagnosed in dozens of American and European patients in recent weeks.
Sylvie Briand, the WHO’s director for Global Infectious Hazard Preparedness said it isn’t clear whether the monkeypox outbreak is just the “tip of the iceberg” or if transmission has already peaked.
Many of the smallpox vaccines and treatments that the U.S. has in storage could also be effective against monkeypox, according to federal health officials.
Pfizer and BioNTech said they will finish submitting data to the FDA “this week” as they seek authorization for the shots, which aren’t yet available to children under 5.
Two cases of the rare infection have been confirmed in the U.S., and a handful of possible cases are being monitored by health officials—but Biden Administration officials say vaccines and treatments are available for the disease, which isn’t as contag…